Global Vaccine Adjuvants Competitive Landscape Professional Research Report 2025
Research Summary
Vaccine adjuvants are substances added to vaccines to enhance and improve the body＇s immune response to the antigen, which is the part of the vaccine that stimulates an immune reaction. Adjuvants play a crucial role in vaccines by amplifying the immune response, leading to increased antibody production and a more robust and long-lasting protection against the targeted pathogen. They work by triggering the innate immune system and promoting the activation of immune cells at the site of vaccination. Common adjuvants include aluminum salts, oil-in-water emulsions, and other immune-stimulating compounds. The use of adjuvants in vaccines allows for the development of effective vaccines with smaller amounts of antigen, reducing costs and improving vaccine efficacy. Vaccine adjuvants contribute significantly to the success of vaccination programs by enhancing the overall effectiveness of vaccines and promoting immunity against infectious diseases.
According to DIResearch's in-depth investigation and research, the global Vaccine Adjuvants market size was valued at XX Million USD in 2024 and is projected to reach XX Million USD by 2032, with a CAGR of XX% (2025-2032). Notably, the China market has changed rapidly in the past few years. By 2024, China's market size is expected to be XX Million USD, representing approximately XX% of the global market share. By 2032, it is anticipated to grow further to XX Million USD, contributing XX% to the worldwide market share.
The major global manufacturers of Vaccine Adjuvants include GSK, CSL Limited, Croda, SEPPIC, Novavax, SPI Pharma, Phibro, SDA BIO, Invivogen, Tj Kaiwei, OZ Biosciences, Brenntag Biosector, MVP Laboratories, Zhuoyue, Aphios etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of Vaccine Adjuvants. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Vaccine Adjuvants market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.
The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the Vaccine Adjuvants market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Vaccine Adjuvants industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Manufacturers of Vaccine Adjuvants Include:
GSK
CSL Limited
Croda
SEPPIC
Novavax
SPI Pharma
Phibro
SDA BIO
Invivogen
Tj Kaiwei
OZ Biosciences
Brenntag Biosector
MVP Laboratories
Zhuoyue
Aphios
Vaccine Adjuvants Product Segment Include:
Aluminum Adjuvant
Emulsions Adjuvant
Others
Vaccine Adjuvants Product Application Include:
Human Vaccine
Veterinary Vaccine
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends
Chapter 2: Global Vaccine Adjuvants Industry PESTEL Analysis
Chapter 3: Global Vaccine Adjuvants Industry Porter’s Five Forces Analysis
Chapter 4: Global Vaccine Adjuvants Major Regional Market Size (Revenue, Sales, Price) and Forecast Analysis
Chapter 5: Global Vaccine Adjuvants Market Size and Forecast by Type and Application Analysis
Chapter 6: North America Vaccine Adjuvants Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 7: Europe Vaccine Adjuvants Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 8: China Vaccine Adjuvants Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 9: APAC (Excl. China) Vaccine Adjuvants Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 10: Latin America Vaccine Adjuvants Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 11: Middle East and Africa Vaccine Adjuvants Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 12: Global Vaccine Adjuvants Competitive Analysis of Key Manufacturers (Sales, Revenue, Market Share, Price, Regional Distribution and Industry Concentration)
Chapter 13: Key Company Profiles (Product Portfolio, Sales, Revenue, Price and Gross Margin)
Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers
Chapter 15: Research Findings and Conclusion
Chapter 16: Methodology and Data Sources
- 1 Vaccine Adjuvants Market Overview
- 1.1 Product Definition and Statistical Scope
- 1.2 Vaccine Adjuvants Product by Type
- 1.2.1 Aluminum Adjuvant
- 1.2.2 Emulsions Adjuvant
- 1.2.3 Others
- 1.3 Vaccine Adjuvants Product by Application
- 1.3.1 Human Vaccine
- 1.3.2 Veterinary Vaccine
- 1.4 Global Vaccine Adjuvants Market Revenue and Sales Analysis
- 1.4.1 Global Vaccine Adjuvants Revenue Market Size Analysis (2020-2032)
- 1.4.2 Global Vaccine Adjuvants Sales Market Size Analysis (2020-2032)
- 1.4.3 Global Vaccine Adjuvants Market Sales Price Trend Analysis (2020-2032)
- 1.5 Vaccine Adjuvants Industry Trends and Innovation
- 1.5.1 Vaccine Adjuvants Industry Trends and Innovation
- 1.5.2 Vaccine Adjuvants Market Drivers and Challenges
- 2 Vaccine Adjuvants Market PESTEL Analysis
- 2.1 Political Factors Analysis
- 2.2 Economic Factors Analysis
- 2.3 Social Factors Analysis
- 2.4 Technological Factors Analysis
- 2.5 Environmental Factors Analysis
- 2.6 Legal Factors Analysis
- 3 Vaccine Adjuvants Market Porter's Five Forces Analysis
- 3.1 Competitive Rivalry
- 3.2 Threat of New Entrants
- 3.3 Bargaining Power of Suppliers
- 3.4 Bargaining Power of Buyers
- 3.5 Threat of Substitutes
- 4 Global Vaccine Adjuvants Market Analysis by Regions
- 4.1 Vaccine Adjuvants Overall Market: 2024 VS 2025 VS 2032
- 4.2 Global Vaccine Adjuvants Revenue and Forecast Analysis (2020-2032)
- 4.2.1 Global Vaccine Adjuvants Revenue and Market Share by Region (2020-2025)
- 4.2.2 Global Vaccine Adjuvants Revenue and Market Share Forecast by Region (2026-2032)
- 4.3 Global Vaccine Adjuvants Sales and Forecast Analysis (2020-2032)
- 4.3.1 Global Vaccine Adjuvants Sales and Market Share by Region (2020-2025)
- 4.3.2 Global Vaccine Adjuvants Sales Forecast by Region (2026-2032)
- 4.4 Global Vaccine Adjuvants Sales Price Trend Analysis (2020-2032)
- 5 Global Vaccine Adjuvants Market Size by Type and Application
- 5.1 Global Vaccine Adjuvants Market Size by Type
- 5.1.1 Global Vaccine Adjuvants Revenue and Forecast Analysis by Type (2020-2032)
- 5.1.2 Global Vaccine Adjuvants Sales and Forecast Analysis by Type (2020-2032)
- 5.2 Global Vaccine Adjuvants Market Size by Application
- 5.2.1 Global Vaccine Adjuvants Revenue and Forecast Analysis by Application (2020-2032)
- 5.2.2 Global Vaccine Adjuvants Sales and Forecast Analysis by Application (2020-2032)
- 6 North America
- 6.1 North America Vaccine Adjuvants Market Size and Growth Rate Analysis (2020-2032)
- 6.2 North America Key Manufacturers Analysis
- 6.3 North America Vaccine Adjuvants Market Size by Type
- 6.3.1 North America Vaccine Adjuvants Sales by Type (2020-2032)
- 6.3.2 North America Vaccine Adjuvants Revenue by Type (2020-2032)
- 6.4 North America Vaccine Adjuvants Market Size by Application
- 6.4.1 North America Vaccine Adjuvants Sales by Application (2020-2032)
- 6.4.2 North America Vaccine Adjuvants Revenue by Application (2020-2032)
- 6.5 North America Vaccine Adjuvants Market Size by Country
- 6.5.1 US
- 6.5.2 Canada
- 7 Europe
- 7.1 Europe Vaccine Adjuvants Market Size and Growth Rate Analysis (2020-2032)
- 7.2 Europe Key Manufacturers Analysis
- 7.3 Europe Vaccine Adjuvants Market Size by Type
- 7.3.1 Europe Vaccine Adjuvants Sales by Type (2020-2032)
- 7.3.2 Europe Vaccine Adjuvants Revenue by Type (2020-2032)
- 7.4 Europe Vaccine Adjuvants Market Size by Application
- 7.4.1 Europe Vaccine Adjuvants Sales by Application (2020-2032)
- 7.4.2 Europe Vaccine Adjuvants Revenue by Application (2020-2032)
- 7.5 Europe Vaccine Adjuvants Market Size by Country
- 7.5.1 Germany
- 7.5.2 France
- 7.5.3 United Kingdom
- 7.5.4 Italy
- 7.5.5 Spain
- 7.5.6 Benelux
- 8 China
- 8.1 China Vaccine Adjuvants Market Size and Growth Rate Analysis (2020-2032)
- 8.2 China Key Manufacturers Analysis
- 8.3 China Vaccine Adjuvants Market Size by Type
- 8.3.1 China Vaccine Adjuvants Sales by Type (2020-2032)
- 8.3.2 China Vaccine Adjuvants Revenue by Type (2020-2032)
- 8.4 China Vaccine Adjuvants Market Size by Application
- 8.4.1 China Vaccine Adjuvants Sales by Application (2020-2032)
- 8.4.2 China Vaccine Adjuvants Revenue by Application (2020-2032)
- 9 APAC (excl. China)
- 9.1 APAC (excl. China) Vaccine Adjuvants Market Size and Growth Rate Analysis (2020-2032)
- 9.2 APAC (excl. China) Key Manufacturers Analysis
- 9.3 APAC (excl. China) Vaccine Adjuvants Market Size by Type
- 9.3.1 APAC (excl. China) Vaccine Adjuvants Sales by Type (2020-2032)
- 9.3.2 APAC (excl. China) Vaccine Adjuvants Revenue by Type (2020-2032)
- 9.4 APAC (excl. China) Vaccine Adjuvants Market Size by Application
- 9.4.1 APAC (excl. China) Vaccine Adjuvants Sales by Application (2020-2032)
- 9.4.2 APAC (excl. China) Vaccine Adjuvants Revenue by Application (2020-2032)
- 9.5 APAC (excl. China) Vaccine Adjuvants Market Size by Country
- 9.5.1 Japan
- 9.5.2 South Korea
- 9.5.3 India
- 9.5.4 Australia
- 9.5.5 Southeast Asia
- 10 Latin America
- 10.1 Latin America Vaccine Adjuvants Market Size and Growth Rate Analysis (2020-2032)
- 10.2 Latin America Key Manufacturers Analysis
- 10.3 Latin America Vaccine Adjuvants Market Size by Type
- 10.3.1 Latin America Vaccine Adjuvants Sales by Type (2020-2032)
- 10.3.2 Latin America Vaccine Adjuvants Revenue by Type (2020-2032)
- 10.4 Latin America Vaccine Adjuvants Market Size by Application
- 10.4.1 Latin America Vaccine Adjuvants Sales by Application (2020-2032)
- 10.4.2 Latin America Vaccine Adjuvants Revenue by Application (2020-2032)
- 10.5 Latin America Vaccine Adjuvants Market Size by Country
- 10.6 Latin America Vaccine Adjuvants Market Size by Country
- 10.6.1 Mexico
- 10.6.2 Brazil
- 11 Middle East & Africa
- 11.1 Middle East & Africa Vaccine Adjuvants Market Size and Growth Rate Analysis (2020-2032)
- 11.2 Middle East & Africa Key Manufacturers Analysis
- 11.3 Middle East & Africa Vaccine Adjuvants Market Size by Type
- 11.3.1 Middle East & Africa Vaccine Adjuvants Sales by Type (2020-2032)
- 11.3.2 Middle East & Africa Vaccine Adjuvants Revenue by Type (2020-2032)
- 11.4 Middle East & Africa Vaccine Adjuvants Market Size by Application
- 11.4.1 Middle East & Africa Vaccine Adjuvants Sales by Application (2020-2032)
- 11.4.2 Middle East & Africa Vaccine Adjuvants Revenue by Application (2020-2032)
- 11.5 Middle East Vaccine Adjuvants Market Size by Country
- 11.5.1 Saudi Arabia
- 11.5.2 South Africa
- 12 Competition by Manufacturers
- 12.1 Global Vaccine Adjuvants Market Sales, Revenue and Price by Key Manufacturers (2021-2025)
- 12.1.1 Global Vaccine Adjuvants Market Sales by Key Manufacturers (2021-2025)
- 12.1.2 Global Vaccine Adjuvants Market Revenue by Key Manufacturers (2021-2025)
- 12.1.3 Global Vaccine Adjuvants Average Sales Price by Manufacturers (2021-2025)
- 12.2 Vaccine Adjuvants Competitive Landscape Analysis and Market Dynamic
- 12.2.1 Vaccine Adjuvants Competitive Landscape Analysis
- 12.2.2 Global Key Manufacturers Headquarter Location and Key Area Sales
- 12.2.3 Market Dynamic
- 13 Key Companies Analysis
- 13.1 GSK
- 13.1.1 GSK Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.1.2 GSK Vaccine Adjuvants Product Portfolio
- 13.1.3 GSK Vaccine Adjuvants Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 13.2 CSL Limited
- 13.2.1 CSL Limited Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.2.2 CSL Limited Vaccine Adjuvants Product Portfolio
- 13.2.3 CSL Limited Vaccine Adjuvants Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 13.3 Croda
- 13.3.1 Croda Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.3.2 Croda Vaccine Adjuvants Product Portfolio
- 13.3.3 Croda Vaccine Adjuvants Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 13.4 SEPPIC
- 13.4.1 SEPPIC Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.4.2 SEPPIC Vaccine Adjuvants Product Portfolio
- 13.4.3 SEPPIC Vaccine Adjuvants Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 13.5 Novavax
- 13.5.1 Novavax Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.5.2 Novavax Vaccine Adjuvants Product Portfolio
- 13.5.3 Novavax Vaccine Adjuvants Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 13.6 SPI Pharma
- 13.6.1 SPI Pharma Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.6.2 SPI Pharma Vaccine Adjuvants Product Portfolio
- 13.6.3 SPI Pharma Vaccine Adjuvants Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 13.7 Phibro
- 13.7.1 Phibro Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.7.2 Phibro Vaccine Adjuvants Product Portfolio
- 13.7.3 Phibro Vaccine Adjuvants Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 13.8 SDA BIO
- 13.8.1 SDA BIO Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.8.2 SDA BIO Vaccine Adjuvants Product Portfolio
- 13.8.3 SDA BIO Vaccine Adjuvants Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 13.9 Invivogen
- 13.9.1 Invivogen Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.9.2 Invivogen Vaccine Adjuvants Product Portfolio
- 13.9.3 Invivogen Vaccine Adjuvants Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 13.10 Tj Kaiwei
- 13.10.1 Tj Kaiwei Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.10.2 Tj Kaiwei Vaccine Adjuvants Product Portfolio
- 13.10.3 Tj Kaiwei Vaccine Adjuvants Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 13.11 OZ Biosciences
- 13.11.1 OZ Biosciences Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.11.2 OZ Biosciences Vaccine Adjuvants Product Portfolio
- 13.11.3 OZ Biosciences Vaccine Adjuvants Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 13.12 Brenntag Biosector
- 13.12.1 Brenntag Biosector Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.12.2 Brenntag Biosector Vaccine Adjuvants Product Portfolio
- 13.12.3 Brenntag Biosector Vaccine Adjuvants Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 13.13 MVP Laboratories
- 13.13.1 MVP Laboratories Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.13.2 MVP Laboratories Vaccine Adjuvants Product Portfolio
- 13.13.3 MVP Laboratories Vaccine Adjuvants Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 13.14 Zhuoyue
- 13.14.1 Zhuoyue Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.14.2 Zhuoyue Vaccine Adjuvants Product Portfolio
- 13.14.3 Zhuoyue Vaccine Adjuvants Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 13.15 Aphios
- 13.15.1 Aphios Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.15.2 Aphios Vaccine Adjuvants Product Portfolio
- 13.15.3 Aphios Vaccine Adjuvants Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 14 Industry Chain Analysis
- 14.1 Vaccine Adjuvants Industry Chain Analysis
- 14.2 Vaccine Adjuvants Industry Raw Material and Suppliers Analysis
- 14.2.1 Vaccine Adjuvants Key Raw Material Supply Analysis
- 14.2.2 Raw Material Suppliers and Contact Information
- 14.3 Vaccine Adjuvants Typical Downstream Customers
- 14.4 Vaccine Adjuvants Sales Channel Analysis
- 15 Research Findings and Conclusion
- 16 Methodology and Data Source
- 16.1 Methodology/Research Approach
- 16.2 Research Scope
- 16.3 Benchmarks and Assumptions
- 16.4 Date Source
- 16.4.1 Primary Sources
- 16.4.2 Secondary Sources
- 16.5 Data Cross Validation
- 16.6 Disclaimer
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook